Advertisement

Supply Chain



Facing ongoing pressure to reduce costs, hospitals and health systems are looking more closely at their supply chains as a source of significant, additional savings.

The FDA approved Novartis' cell therapy Kymriah to treat an additional type of blood cancer, the drugmaker announced May 1.

Advertisement

Most Read

Advertisement
Advertisement